Related references
Note: Only part of the references are listed.1-Deoxnojirinicin and its Derivatives: A Mini Review of the Literature
Haijun Wang et al.
CURRENT MEDICINAL CHEMISTRY (2021)
Inhibition of SARS-CoV 3CL protease by flavonoids
Seri Jo et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China
Aiping Wu et al.
CELL HOST & MICROBE (2020)
An interactive web-based dashboard to track COVID-19 in real time
Ensheng Dong et al.
LANCET INFECTIOUS DISEASES (2020)
A Review of Small Molecule Inhibitors and Functional Probes of Human Cathepsin L
Dibyendu Dana et al.
MOLECULES (2020)
Another Decade, Another Coronavirus
Stanley Perlman
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Renhong Yan et al.
SCIENCE (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
Alexander E. Gorbalenya et al.
NATURE MICROBIOLOGY (2020)
Ivermectin and COVID-19: Keeping Rigor in Times of Urgency
Carlos Chaccour et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2020)
Ombitasvir/paritaprevir/ritonavir & dasabuvir ± ribavirin following protease inhibitors failure-a prospective multi-centre trial
Liat Deutsch et al.
BMC INFECTIOUS DISEASES (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
Shuai Xia et al.
CELL RESEARCH (2020)
Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model
Hua-Hao Fan et al.
CHINESE MEDICAL JOURNAL (2020)
Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak
Tao Zhang et al.
CURRENT BIOLOGY (2020)
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19) A Review
James M. Sanders et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
Calvin J. Gordon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir
Wanchao Yin et al.
SCIENCE (2020)
A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV
Meng Yuan et al.
SCIENCE (2020)
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
Timothy P. Sheahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2020)
Matrix metalloproteinase 9 facilitates Zika virus invasion of the testis by modulating the integrity of the blood-testis barrier
Lixia Hui et al.
PLoS Pathogens (2020)
Viral genomics in Ebola virus research
Nicholas Di Paola et al.
NATURE REVIEWS MICROBIOLOGY (2020)
TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes
Ruochen Zang et al.
SCIENCE IMMUNOLOGY (2020)
Natural products and their derivatives against coronavirus: A review of the non-clinical and pre-clinical data
Muhammad T. Islam et al.
PHYTOTHERAPY RESEARCH (2020)
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Leon Caly et al.
ANTIVIRAL RESEARCH (2020)
Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin
Petra Krafcikova et al.
NATURE COMMUNICATIONS (2020)
EMBRACE OF UNPROVEN COVID TREATMENT HINDERS DRUG TRIALS
Emiliano Rodriguez Mega
NATURE (2020)
Nature as a treasure trove of potential anti-SARS-CoV drug leads: a structural/mechanistic rationale
Ahmed M. Sayed et al.
RSC ADVANCES (2020)
Dual targeting of dengue virus virions and NS1 protein with the heparan sulfate mimic PG545
Naphak Modhiran et al.
ANTIVIRAL RESEARCH (2019)
The remarkable history of the hepatitis C virus
Stanislas Pol et al.
GENES AND IMMUNITY (2019)
The Natural Product Eugenol Is an Inhibitor of the Ebola Virus In Vitro
Thomas Lane et al.
PHARMACEUTICAL RESEARCH (2019)
Tick-borne encephalitis virus: molecular determinants of neuropathogenesis of an emerging pathogen
Aurelie Velay et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2019)
Therapeutic strategies to target the Ebola virus life cycle
Thomas Hoenen et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Cross-serotype interactions and disease outcome prediction of dengue infections in Vietnam
R. Aguas et al.
SCIENTIFIC REPORTS (2019)
Griffithsin, a Highly Potent Broad-Spectrum Antiviral Lectin from Red Algae: From Discovery to Clinical Application
Choongho Lee
MARINE DRUGS (2019)
Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV
Stefanie A. Ehrhardt et al.
NATURE MEDICINE (2019)
In Vivo Characterization of Tick-Borne Encephalitis Virus in Bank Voles (Myodes glareolus)
Anna Michelitsch et al.
VIRUSES-BASEL (2019)
The Roles of Ebola Virus Soluble Glycoprotein in Replication, Pathogenesis, and Countermeasure Development
Wenjun Zhu et al.
VIRUSES-BASEL (2019)
Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates
John J. Suschak et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
Discovery of a small molecule inhibitor targeting dengue virus NS5 RNA-dependent RNA polymerase
Hideaki Shimizu et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
Twenty years of West Nile virus spread and evolution in the Americas visualized by Nextstrain
James Hadfield et al.
PLOS PATHOGENS (2019)
Discovery of Ganoderma lucidum triterpenoids as potential inhibitors against Dengue virus NS2B-NS3 protease
Shiv Bharadwaj et al.
SCIENTIFIC REPORTS (2019)
Bcl-2 regulates pyroptosis and necroptosis by targeting BH3-like domains in GSDMD and MLKL
Chong-Shan Shi et al.
CELL DEATH DISCOVERY (2019)
Furin-mediated protein processing in infectious diseases and cancer
Elisabeth Braun et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2019)
Dengue virus NS2 and NS4: Minor proteins, mammoth roles
Sindhoora Bhargavi Gopala Reddy et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Discovery and evolution of aloperine derivatives as novel anti-filovirus agents through targeting entry stage
Xin Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Drug repurposing approaches to fight Dengue virus infection and related diseases
Lorenzo Botta et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2018)
Japanese encephalitis - the prospects for new treatments
Lance Turtle et al.
NATURE REVIEWS NEUROLOGY (2018)
History, epidemiology and diagnostics of dengue in the American and Brazilian contexts: a review
Tiago Souza Salles et al.
PARASITES & VECTORS (2018)
Identification of Ellagic Acid from Plant Rhodiola rosea L. as an Anti-Ebola Virus Entry Inhibitor
Qinghua Cui et al.
VIRUSES-BASEL (2018)
Identification of Myricetin as an Ebola Virus VP35-Double-Stranded RNA Interaction Inhibitor through a Novel Fluorescence-Based Assay
Gian Luca Daino et al.
BIOCHEMISTRY (2018)
Dolutegravir/Rilpivirine: A Review in HIV-1 Infection
Hannah A. Blair
DRUGS (2018)
Triterpenoids manipulate a broad range of virus-host fusion via wrapping the HR2 domain prevalent in viral envelopes
Longlong Si et al.
SCIENCE ADVANCES (2018)
The calmodulin antagonist W-7 (N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride) inhibits DENV infection in Huh-7 cells
Patricia Bautista-Carbajal et al.
VIROLOGY (2017)
Inhibitors compounds of the flavivirus replication process
Leidy L. Garcia et al.
VIROLOGY JOURNAL (2017)
N-Heterocyclic borneol derivatives as inhibitors of Marburg virus glycoprotein-mediated VSIV pseudotype entry
A. A. Kononova et al.
MEDCHEMCOMM (2017)
The Natural Product Cavinafungin Selectively Interferes with Zika and Dengue Virus Replication by Inhibition of the Host Signal Peptidase
David Estoppey et al.
CELL REPORTS (2017)
Dengue virus NS1 cytokine-independent vascular leak is dependent on endothelial glycocalyx components
Dustin R. Glasner et al.
PLOS PATHOGENS (2017)
The natural compound silvestrol is a potent inhibitor of Ebola virus replication
Nadine Biedenkopf et al.
ANTIVIRAL RESEARCH (2017)
TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections
Li Wen Shen et al.
BIOCHIMIE (2017)
Structural basis of Zika virus methyltransferase inhibition by sinefungin
Kamil Hercik et al.
ARCHIVES OF VIROLOGY (2017)
Dengue Virus prM-Specific Human Monoclonal Antibodies with Virus Replication-Enhancing Properties Recognize a Single Immunodominant Antigenic Site
Scott A. Smith et al.
JOURNAL OF VIROLOGY (2016)
Secondary Structure and Membrane Topology of the Full-Length Dengue Virus NS4B in Micelles
Yan Li et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Identification of entry inhibitors of Ebola virus pseudotyped vectors from a myxobacterial compound library
Simon Beck et al.
ANTIVIRAL RESEARCH (2016)
Progress and prospects on DENV protease inhibitors
Ajay Kumar Timiri et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
Thanigaimalai Pillaiyar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Microcephaly and Zika virus infection
Laura C. Rodrigues
LANCET (2016)
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
Travis K. Warren et al.
NATURE (2016)
SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity
Tomonari Muramatsu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Dengue Virus NS1 Disrupts the Endothelial Glycocalyx, Leading to Hyperpermeability
Henry Puerta-Guardo et al.
PLOS PATHOGENS (2016)
Inhibitor Recognition Specificity of MERS-CoV Papain-like Protease May Differ from That of SARS-CoV
Hyun Lee et al.
ACS CHEMICAL BIOLOGY (2015)
The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds
Yahira M. Baez-Santos et al.
ANTIVIRAL RESEARCH (2015)
The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development
Dahai Luo et al.
ANTIVIRAL RESEARCH (2015)
Ebola virus (EBOV) infection: Therapeutic strategies
Erik De Clercq
BIOCHEMICAL PHARMACOLOGY (2015)
Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists
Han Cheng et al.
JOURNAL OF VIROLOGY (2015)
Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus
Ilhem Messaoudi et al.
NATURE REVIEWS MICROBIOLOGY (2015)
Crystal structure of dengue virus methyltransferase without S-adenosyl-L-methionine
Christian G. Noble et al.
ANTIVIRAL RESEARCH (2014)
Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model
Lisa Oestereich et al.
ANTIVIRAL RESEARCH (2014)
Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of dengue virus
Ruben Soto-Acosta et al.
ANTIVIRAL RESEARCH (2014)
Phenolic phytochemical displaying SARS-CoV papain-like protease inhibition from the seeds of Psoralea corylifolia
Dae Wook Kim et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2014)
The Marine Cyanobacterial Metabolite Gallinamide A Is a Potent and Selective Inhibitor of Human Cathepsin L
Bailey Miller et al.
JOURNAL OF NATURAL PRODUCTS (2014)
Coronaviruses: Important Emerging Human Pathogens
Christopher M. Coleman et al.
JOURNAL OF VIROLOGY (2014)
Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430
Travis K. Warren et al.
NATURE (2014)
Small molecule inhibitors of ER α-glucosidases are active against multiple hemorrhagic fever viruses
Jinhong Chang et al.
ANTIVIRAL RESEARCH (2013)
Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia tomentosa
Jung Keun Cho et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Discovery and Biological Activity of New Chondramides from Chondromyces sp.
Jennifer Herrmann et al.
CHEMBIOCHEM (2013)
The Spike Protein of the Emerging Betacoronavirus EMC Uses a Novel Coronavirus Receptor for Entry, Can Be Activated by TMPRSS2, and Is Targeted by Neutralizing Antibodies
Stefanie Gierer et al.
JOURNAL OF VIROLOGY (2013)
Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
Guangwen Lu et al.
NATURE (2013)
Escape from Flatland 2: complexity and promiscuity
Frank Lovering
MEDCHEMCOMM (2013)
Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial
Satoru Watanabe et al.
ANTIVIRAL RESEARCH (2012)
Diarylheptanoids from Alnus japonica Inhibit Papain-Like Protease of Severe Acute Respiratory Syndrome Coronavirus
Ji-Young Park et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2012)
Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
Ji-Young Park et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13
Mi-Sun Yu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Design, Synthesis, and Biological Evaluation of N-Alkylated Deoxynojirimycin (DNJ) Derivatives for the Treatment of Dengue Virus Infection
Wenquan Yu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Simultaneous Treatment of Human Bronchial Epithelial Cells with Serine and Cysteine Protease Inhibitors Prevents Severe Acute Respiratory Syndrome Coronavirus Entry
Miyuki Kawase et al.
JOURNAL OF VIROLOGY (2012)
The Role of Severe Acute Respiratory Syndrome (SARS)-Coronavirus Accessory Proteins in Virus Pathogenesis
Ruth McBride et al.
VIRUSES-BASEL (2012)
Forty-Five Years of Marburg Virus Research
Kristina Brauburger et al.
VIRUSES-BASEL (2012)
Reston ebolavirus in Humans and Animals in the Philippines: A Review
Mary Elizabeth G. Miranda et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Ebola virus entry requires the cholesterol transporter Niemann-Pick C1
Jan E. Carette et al.
NATURE (2011)
T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus
Andrew S. Kondratowicz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Broad-Spectrum In Vitro Activity and In Vivo Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family Coronaviridae
Barry R. O'Keefe et al.
JOURNAL OF VIROLOGY (2010)
Ebolavirus Is Internalized into Host Cells via Macropinocytosis in a Viral Glycoprotein-Dependent Manner
Asuka Nanbo et al.
PLOS PATHOGENS (2010)
Antiviral activity of geneticin against dengue virus
Xianchao G. Zhang et al.
ANTIVIRAL RESEARCH (2009)
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Frank Lovering et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Discovery of Swine as a Host for the Reston ebolavirus
Roger W. Barrette et al.
SCIENCE (2009)
Isolation of Genetically Diverse Marburg Viruses from Egyptian Fruit Bats
Jonathan S. Towner et al.
PLOS PATHOGENS (2009)
Matrix metalloproteinase 9 facilitates West Nile Virus entry into the brain
Penghua Wang et al.
JOURNAL OF VIROLOGY (2008)
Processsing of capsid protein by Cathepsin L plays a crucial role in replication of Japanese encephalitis virus in neural and macrophage cells
Yoshio Mori et al.
JOURNAL OF VIROLOGY (2007)
Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction
Tin-Yun Ho et al.
ANTIVIRAL RESEARCH (2007)
Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein
Bruno Sainz et al.
VIRUS RESEARCH (2006)
Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation
Wataru Kamitani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Subcellular localization and membrane topology of the dengue virus type 2 non-structural protein 4B
S Miller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Complete genome sequence of an Ebola virus (Sudan species) responsible for a 2000 outbreak of human disease in Uganda
A Sanchez et al.
VIRUS RESEARCH (2005)
Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry
G Simmons et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo
K Whitby et al.
JOURNAL OF VIROLOGY (2005)
Identification of natural compounds with antiviral activities against SARS-associated coronavirus
SY Li et al.
ANTIVIRAL RESEARCH (2005)
Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection
K Chandran et al.
SCIENCE (2005)
Studies of Ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: Involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha
A Yonezawa et al.
JOURNAL OF VIROLOGY (2005)
Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry
A Takada et al.
JOURNAL OF VIROLOGY (2004)
Small molecules targeting severe acute respiratory syndrome human coronavirus
CY Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Severe acute respiratory syndrome coroavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides
BJ Bosch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Silvestrol and episilvestrol, potential anticancer rocaglate derivatives from Aglaia silvestris
BY Hwang et al.
JOURNAL OF ORGANIC CHEMISTRY (2004)
Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus
LG Barrientos et al.
ANTIVIRAL RESEARCH (2003)
Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control
MR Hillman
VACCINE (2002)
Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP
T Noda et al.
JOURNAL OF VIROLOGY (2002)
Antiviral effects of an iminosugar derivative on flavivirus infections
SF Wu et al.
JOURNAL OF VIROLOGY (2002)
Downregulation of β1 integrins by Ebola virus glycoprotein:: Implication for virus entry
A Takada et al.
VIROLOGY (2000)
Bioactive marine metabolites.: Part 104.: Miraziridine A, a novel cysteine protease inhibitor from the marine sponge Theonella aff. mirabilis
Y Nakao et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2000)
Share Paper
